Cite
HARVARD Citation
Pierga, J. et al. (2017). Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab. Annals of oncology. pp. 103-109. [Online].